She Y[au] - Search Results

Year	Number of Results
1979	1
1980	1
1981	1
1982	2
1983	1
1984	4
1985	3
1987	2
1988	1
1990	1
1991	1
1995	2
1999	1
2000	2
2001	4
2002	11
2003	9
2004	12
2005	14
2006	10
2007	13
2008	14
2009	13
2010	19
2011	17
2012	32
2013	18
2014	32
2015	35
2016	37
2017	59
2018	65
2019	96
2020	100
2021	121
2022	16

1

Pore-forming activity and structural autoinhibition of the gasdermin family.

Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F. Ding J, et al. Among authors: she y. Nature. 2016 Jul 7;535(7610):111-6. doi: 10.1038/nature18590. Epub 2016 Jun 8. Nature. 2016. PMID: 27281216

2

Is Plant Sterols a Good Strategy to Lower Cholesterol?

Chen Y, She Y, Kaur R, Guo N, Zhang X, Zhang R, Gou X. Chen Y, et al. Among authors: she y. J Oleo Sci. 2019 Sep 4;68(9):811-816. doi: 10.5650/jos.ess19116. Epub 2019 Aug 14. J Oleo Sci. 2019. PMID: 31413246 Free article. Review.

3

Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.

She Y, Jin Z, Wu J, Deng J, Zhang L, Su H, Jiang G, Liu H, Xie D, Cao N, Ren Y, Chen C. She Y, et al. JAMA Netw Open. 2020 Jun 1;3(6):e205842. doi: 10.1001/jamanetworkopen.2020.5842. JAMA Netw Open. 2020. PMID: 32492161 Free PMC article.

4

Necrostatin-1 protects C2C12 myotubes from CoCl2-induced hypoxia.

Chen R, Xu J, She Y, Jiang T, Zhou S, Shi H, Li C. Chen R, et al. Among authors: she y. Int J Mol Med. 2018 May;41(5):2565-2572. doi: 10.3892/ijmm.2018.3466. Epub 2018 Feb 6. Int J Mol Med. 2018. PMID: 29436688 Free PMC article.

5

N⁶-methyladenosine-modified circIGF2BP3 inhibits CD8⁺ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.

Liu Z, Wang T, She Y, Wu K, Gu S, Li L, Dong C, Chen C, Zhou Y. Liu Z, et al. Among authors: she y. Mol Cancer. 2021 Aug 20;20(1):105. doi: 10.1186/s12943-021-01398-4. Mol Cancer. 2021. PMID: 34416901 Free PMC article.

6

USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy.

Liu T, Wang L, Liang P, Wang X, Liu Y, Cai J, She Y, Wang D, Wang Z, Guo Z, Bates S, Xia X, Huang J, Cui J. Liu T, et al. Among authors: she y. Cell Mol Immunol. 2021 Oct;18(10):2431-2442. doi: 10.1038/s41423-020-00567-7. Epub 2020 Oct 23. Cell Mol Immunol. 2021. PMID: 33097834

7

Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose.

Zhou P, She Y, Dong N, Li P, He H, Borio A, Wu Q, Lu S, Ding X, Cao Y, Xu Y, Gao W, Dong M, Ding J, Wang DC, Zamyatina A, Shao F. Zhou P, et al. Among authors: she y. Nature. 2018 Sep;561(7721):122-126. doi: 10.1038/s41586-018-0433-3. Epub 2018 Aug 15. Nature. 2018. PMID: 30111836

8

Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome.

Wang LQ, Liu T, Yang S, Sun L, Zhao ZY, Li LY, She YC, Zheng YY, Ye XY, Bao Q, Dong GH, Li CW, Cui J. Wang LQ, et al. Among authors: she yc. Nat Commun. 2021 May 18;12(1):2915. doi: 10.1038/s41467-021-23201-0. Nat Commun. 2021. PMID: 34006824 Free PMC article.

9

[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.

Tian H, Hou L, Xiong YM, Huang JX, She YJ, Bi XB, Song XR. Tian H, et al. Among authors: she yj. Oncol Rep. 2022 Mar;47(3):54. doi: 10.3892/or.2022.8265. Epub 2022 Jan 18. Oncol Rep. 2022. PMID: 35039879

10

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker.

He B, Dong D, She Y, Zhou C, Fang M, Zhu Y, Zhang H, Huang Z, Jiang T, Tian J, Chen C. He B, et al. Among authors: she y. J Immunother Cancer. 2020 Jul;8(2):e000550. doi: 10.1136/jitc-2020-000550. J Immunother Cancer. 2020. PMID: 32636239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results